<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Atossa Genetics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven C. Quay, MD, PhD
    • FOUNDED
      2009
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Mustang Bio, Inc.

    Mustang Bio, Inc.

    Mustang Bio, Inc. (“Mustang”), a Fortress Biotech Company, is a clinical-stage...

    Mustang Bio, Inc. (“Mustang”), a Fortress B...

    Filing Type:    PU
    Phibro Animal Health Corporation

    Phibro Animal Health Corporation

    Phibro Animal Health Corporation is a leading global diversified animal health and...

    Phibro Animal Health Corporation is a leading g...

    Filing Type:    PU
    Precision BioSciences, Inc.

    Precision BioSciences, Inc.

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietar...

    Precision BioSciences is dedicated to improving...

    Filing Type:    PU
    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc.

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a clinical-stage biopharmaceutical c...

    Aimmune Therapeutics, Inc. (Nasdaq: AIMT), is a...

    Filing Type:    PU
    Neurotez Inc.

    Neurotez Inc.

    We have used biochemical, molecular & cell biology and in vivo models to screen, i...

    We have used biochemical, molecular & cell biol...

    Amount Raised:    $7,656.00
    Fundraising Status:    EC
    Filing Type:    CF
    Antares Pharma, Inc.

    Antares Pharma, Inc.

    Antares Pharma is a specialty pharmaceutical company that combines drug developmen...

    Antares Pharma is a specialty pharmaceutical co...

    Filing Type:    PU
    Oncolytics Biotech Inc.

    Oncolytics Biotech Inc.

    Oncolytics is focused on obtaining regulatory approval for pelareorep for metastat...

    Oncolytics is focused on obtaining regulatory a...

    Filing Type:    PU
    Odonate Therapeutics, Inc.

    Odonate Therapeutics, Inc.

    We are a pharmaceutical company dedicated to the development of best-in-class ther...

    We are a pharmaceutical company dedicated to th...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.